Inmagene announces formation of Celexor Bio based on its anti-ILT7 mAb with enhanced pDC depletion function
Article Date
September 21, 2023
This article is featured on another website.
Go to article
October 4, 2023
BioCentury-BayHelix East-West Biopharma Summit – October 2-4, 2023
October 2-4 Cambridge, Massachusetts For more information, visit: https://conferences.biocentury.com/east-west-summit
October 4, 2023
BioCentury-BayHelix East-West Biopharma Summit – October 2-4, 2023
October 2-4 Cambridge, Massachusetts For more information, visit: https://conferences.biocentury.com/east-west-summit
November 6, 2023
Myrtelle Announces Presentation at the 5 th Annual Gene Therapy for Neurological Disorders Summit: Optimizing Gene Therapies Targeting the CNS to Deliver Safe & Efficacious Treatment Options For Neurological Disorder Patients
Wakefield, Mass., November 7, 2023 – Myrtelle Inc. (“Myrtelle” or the “Company”), a clinical-stage gene therapy company focused on developing transformative treatments for neurodegenerative diseases…
November 6, 2023
Myrtelle Announces Presentation at the 5 th Annual Gene Therapy for Neurological Disorders Summit: Optimizing Gene Therapies Targeting the CNS to Deliver Safe & Efficacious Treatment Options For Neurological Disorder Patients
Wakefield, Mass., November 7, 2023 – Myrtelle Inc. (“Myrtelle” or the “Company”), a clinical-stage gene therapy company focused on developing transformative treatments for neurodegenerative diseases…